Uhlmann Rejoinder to: Taubman’s “Letter to the Editor”

Excerpt

The challenges of integrating new genetic tests into healthcare, using the example of hereditary breast cancer, were recently raised by Resta (2009) in his Commentary “Unprepared, Understaffed and Unplanned: Thoughts on the Practical Implications of Discovering New Breast and Ovarian Cancer Causing Genes” and in Commentary responses by Hampel (2009) and Uhlmann (2009). I appreciate the thoughtful points that Dr. Edward Taubman makes in his Letter to the Editor (2010) about these Commentaries. While I agree with Dr. Taubman that genetic testing companies and insurers are key players, I respectfully disagree about the roles he proposes for each of them in informing patients about genetic testing advances. …